Literature DB >> 24673522

Role of high mobility group box 1 and its signaling pathways in renal diseases.

Tian-Biao Zhou1.   

Abstract

The high mobility group box 1 (HMGB1) protein, a member of the high mobility group nuclear protein family and an endogenous ligand for TLR2/4 and RAGE (receptor for advanced glycation end products), is one of the most evolutionarily conserved proteins and it has recently emerged as an extracellular signaling factor with key roles in cell differentiation, proliferation and disease pathogenesis. The present data indicate that HMGB1 is one of most important proinflammatory cytokines, and plays an important role in renal diseases. The literatures were searched extensively and this review was performed to sum up the role of HMGB1 in renal diseases.

Entities:  

Keywords:  Acute kidney injury; HMGB1; chronic kidney disease; diabetic nephropathy; granulomatous nephritis; high mobility group box 1; signaling pathways

Mesh:

Substances:

Year:  2014        PMID: 24673522     DOI: 10.3109/10799893.2014.904875

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

1.  HMGB1, TGF-β and NF-κB are associated with chronic allograft nephropathy.

Authors:  Shi-Qi Zhao; Zhen-Zhen Xue; Ling-Zhang Wang
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

2.  Ischemic preconditioning attenuates acute lung injury after partial liver transplantation.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-04-20

3.  microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.

Authors:  Zhe Liu; Yuanhong Xu; Jin Long; Kejian Guo; Chunlin Ge; Ruixia Du
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

4.  High mobility group box 1 as a biomarker in critically ill patients.

Authors:  Eray Yagmur; Lukas Buendgens; Ulf Herbers; Anne Beeretz; Ralf Weiskirchen; Ger H Koek; Christian Trautwein; Frank Tacke; Alexander Koch
Journal:  J Clin Lab Anal       Date:  2018-06-03       Impact factor: 2.352

Review 5.  The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review.

Authors:  Xuanbin Wang; Longchao Xiang; Hongliang Li; Ping Chen; Yibin Feng; Jingxuan Zhang; Nian Yang; Fei Li; Ye Wang; Quifang Zhang; Fang Li; Fengjun Cao
Journal:  Int J Mol Sci       Date:  2015-09-17       Impact factor: 5.923

6.  High-mobility group box 1 protein antagonizes the immunosuppressive capacity and therapeutic effect of mesenchymal stem cells in acute kidney injury.

Authors:  Shuo Wang; Songjie Cai; Weitao Zhang; Xigao Liu; Yan Li; Chao Zhang; Yigang Zeng; Ming Xu; Ruiming Rong; Tianshu Yang; Benkang Shi; Anil Chandraker; Cheng Yang; Tongyu Zhu
Journal:  J Transl Med       Date:  2020-04-20       Impact factor: 5.531

7.  Soluble Receptor for Advanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways.

Authors:  Xu Wu; Wenyu Gu; Huan Lu; Chengying Liu; Biyun Yu; Hui Xu; Yaodong Tang; Shanqun Li; Jian Zhou; Chuan Shao
Journal:  Oxid Med Cell Longev       Date:  2016-09-05       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.